• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

    5/29/25 4:30:00 PM ET
    $MTX
    $SMG
    $XRAY
    Major Chemicals
    Basic Materials
    Agricultural Chemicals
    Industrials
    Get the next $MTX alert in real time by email

    CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025.

    Mr. Garth brings nearly 30 years of proven financial management expertise to Dentsply Sirona, with a focus on driving value creation. He most recently served as Chief Financial Officer & Chief Administrative Officer of The Scotts Miracle-Gro Company, a global leader of branded consumer lawn and garden products. Prior to ScottsMiracle-Gro, Mr. Garth held numerous financial leadership roles at large, multinational companies, including Minerals Technology Inc. and Alcoa Corporation.

    "We are pleased to welcome Matt as our new CFO," said Simon Campion, President and Chief Executive Officer of Dentsply Sirona. "He is a seasoned executive with a strong financial background and track record of delivering results. He brings deep expertise in driving organizational transformation and engaging with investors and capital markets. Matt joins us at a critical time in our transformational journey and as our industry continues to evolve, we are confident that he will play an instrumental role in helping Dentsply Sirona advance our strategic agenda to drive sustainable growth and unlock greater shareholder value."

    Mr. Garth said, "I'm thrilled to join Dentsply Sirona and be part of this exciting journey. I look forward to joining the team to help advance our financial, operational, and strategic goals, execute with focus and discipline, and ultimately deliver long-term profitable growth and value creation."

    About Matthew E. Garth

    Mr. Garth was most recently Executive Vice President, Chief Financial Officer & Chief Administrative Officer of The Scotts Miracle-Gro Company (NYSE:SMG), the world's largest marketer of branded consumer products for lawn and garden care. He joined ScottsMiracle-Gro in 2022 during a critical post-pandemic period and helped stabilize the organization, deliver on many key financial priorities and lead development of mid- and long-term value optimizing strategic plans.

    Prior to ScottsMiracle-Gro, Mr. Garth served as Senior Vice President, Finance and Treasury, and Chief Financial Officer of Minerals Technologies, Inc., (NYSE:MTX), a leading, technology-driven specialty minerals company, where he had global responsibility for finance, tax, treasury, audit, investor relations, information technology and shared services. Prior to Minerals Technologies, Mr. Garth held senior financial roles of increasing responsibility at Alcoa Corporation, including as CFO of two multi-billion-dollar business units. Mr. Garth started his career at Thomson Financial.

    Mr. Garth holds a Bachelor of Science in Accounting from the University of Delaware and an MBA from Columbia University.

    About Dentsply Sirona

    Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona's innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona's headquarters is located in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

    Contact Information

    Investors:

    Andrea Daley

    Vice President, Investor Relations

    +1-704-591-8631

    InvestorRelations@dentsplysirona.com

    Press:

    Marion Par-Weixlberger

    Vice President, Public Relations & Corporate Communications

    +43 676 848414588

    marion.par-weixlberger@dentsplysirona.com



    Primary Logo

    Get the next $MTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTX
    $SMG
    $XRAY

    CompanyDatePrice TargetRatingAnalyst
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    DENTSPLY SIRONA Inc.
    $XRAY
    11/7/2025Outperform → Mkt Perform
    William Blair
    Scotts Miracle-Gro Company
    $SMG
    11/6/2025$70.00Hold → Buy
    Stifel
    Scotts Miracle-Gro Company
    $SMG
    6/9/2025$71.00Buy → Hold
    Stifel
    DENTSPLY SIRONA Inc.
    $XRAY
    4/15/2025$14.00Overweight → Equal-Weight
    Morgan Stanley
    Scotts Miracle-Gro Company
    $SMG
    4/7/2025$69.00Hold → Buy
    Jefferies
    Scotts Miracle-Gro Company
    $SMG
    4/2/2025$70.00Hold → Buy
    Truist
    DENTSPLY SIRONA Inc.
    $XRAY
    3/13/2025Buy → Hold
    Needham
    More analyst ratings

    $MTX
    $SMG
    $XRAY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Minerals Technologies Inc.

    SCHEDULE 13G/A - MINERALS TECHNOLOGIES INC (0000891014) (Subject)

    2/6/26 1:11:50 PM ET
    $MTX
    Major Chemicals
    Basic Materials

    Amendment: SEC Form SCHEDULE 13G/A filed by Minerals Technologies Inc.

    SCHEDULE 13G/A - MINERALS TECHNOLOGIES INC (0000891014) (Subject)

    2/5/26 1:31:51 PM ET
    $MTX
    Major Chemicals
    Basic Materials

    SEC Form 10-Q filed by Scotts Miracle-Gro Company

    10-Q - SCOTTS MIRACLE-GRO CO (0000825542) (Filer)

    2/4/26 4:03:57 PM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $MTX
    $SMG
    $XRAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kingdon Mark D converted options into 165 shares, increasing direct ownership by 1% to 11,658 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/5/26 11:56:22 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Director Hanft Adam converted options into 336 shares, increasing direct ownership by 0.75% to 45,018 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/5/26 11:56:28 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Chairman & CEO Hagedorn James covered exercise/tax liability with 16,677 shares, decreasing direct ownership by 16% to 87,436 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/5/26 11:56:16 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $MTX
    $SMG
    $XRAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Dentsply Sirona with a new price target

    Barclays initiated coverage of Dentsply Sirona with a rating of Underweight and set a new price target of $12.00

    12/9/25 8:44:01 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona downgraded by William Blair

    William Blair downgraded Dentsply Sirona from Outperform to Mkt Perform

    11/7/25 8:28:06 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Scotts Miracle-Gro upgraded by Stifel with a new price target

    Stifel upgraded Scotts Miracle-Gro from Hold to Buy and set a new price target of $70.00

    11/6/25 8:42:26 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $MTX
    $SMG
    $XRAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Varon Leslie F bought $99,999 worth of shares (9,337 units at $10.71), increasing direct ownership by 19% to 57,343 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    11/25/25 5:26:33 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    EVP, CFO & CAO Scheiwer Mark J bought $109,763 worth of shares (1,790 units at $61.32), increasing direct ownership by 21% to 10,130 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    9/4/25 11:22:10 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Director Motwani Rocky bought $20,094 worth of shares (370 units at $54.31), increasing direct ownership by 45% to 1,192 units (SEC Form 4)

    4 - MINERALS TECHNOLOGIES INC (0000891014) (Issuer)

    6/17/25 11:23:01 AM ET
    $MTX
    Major Chemicals
    Basic Materials

    $MTX
    $SMG
    $XRAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

    CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at http

    2/5/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Minerals Technologies Inc. Announces 2025 Fourth Quarter and Full Year Financial Results

    NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE:MTX) ("MTI"), a leading, technology-driven specialty minerals company, today reported earnings per share for the fourth quarter ended December 31, 2025, of $1.19, or $1.27 excluding special items. "This past year, MTI demonstrated our strength as a company through the resilience and ingenuity of our teams around the world. We navigated multiple market challenges while remaining focused on our growth projects and strategic initiatives," said Douglas T. Dietrich, MTI's Chairman and Chief Executive Officer. "The timely investments we made last year position us for a strong 2026. Furthermore, our financial strength,

    1/29/26 5:00:00 PM ET
    $MTX
    Major Chemicals
    Basic Materials

    ScottsMiracle-Gro Reports First Quarter Results and Advancement of Key Strategic Initiatives

    Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE:SMG), the leading marketer of branded consumer lawn and garden products in North America, today reported results for the first quarter ended December 27, 2025. The Company also announced that it is in advanced discussions for the sale of its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter. In conjunction with the pending divestiture, effective in its first quarter of fiscal 2026, the Company classified its results of operations for all

    1/28/26 7:00:00 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $MTX
    $SMG
    $XRAY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

    CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device

    1/12/26 9:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

    CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer (CCO), effective October 6, 2025. The appointment is designed to sharpen the Company's focus on the customer by aligning its Global Business Units and Commercial Organizations more closely - streamlining how Dentsply Sirona works and delivers. Mr. Denti is a global business leader with over 25 years of experience driving transformative growth in the Medical Device and Consumer Health sectors. His expertise spans sales, marketing, strategic planning, and successf

    10/2/25 8:30:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $MTX
    $SMG
    $XRAY
    Financials

    Live finance-specific insights

    View All

    Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

    CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at http

    2/5/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Minerals Technologies Inc. Announces 2025 Fourth Quarter and Full Year Financial Results

    NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE:MTX) ("MTI"), a leading, technology-driven specialty minerals company, today reported earnings per share for the fourth quarter ended December 31, 2025, of $1.19, or $1.27 excluding special items. "This past year, MTI demonstrated our strength as a company through the resilience and ingenuity of our teams around the world. We navigated multiple market challenges while remaining focused on our growth projects and strategic initiatives," said Douglas T. Dietrich, MTI's Chairman and Chief Executive Officer. "The timely investments we made last year position us for a strong 2026. Furthermore, our financial strength,

    1/29/26 5:00:00 PM ET
    $MTX
    Major Chemicals
    Basic Materials

    ScottsMiracle-Gro Reports First Quarter Results and Advancement of Key Strategic Initiatives

    Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE:SMG), the leading marketer of branded consumer lawn and garden products in North America, today reported results for the first quarter ended December 27, 2025. The Company also announced that it is in advanced discussions for the sale of its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter. In conjunction with the pending divestiture, effective in its first quarter of fiscal 2026, the Company classified its results of operations for all

    1/28/26 7:00:00 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $MTX
    $SMG
    $XRAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/14/24 1:22:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/12/24 4:23:31 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care